DXCMDexCom, Inc.

$26B

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$171M+24.3% YoY

Gross Profit

$118M68.9% margin

Operating Income

-$14M-8.0% margin

Net Income

$3M1.7% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+19.9%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$2M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$796M

Total Liabilities

$442M

Stockholders' Equity

$354M

Cash & Equivalents

$396M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$171M	$137M	+24.3%
Gross Profit	$118M	$86M	+37.4%
Operating Income	-$14M	-$20M	+32.3%
Net Income	$3M	-$20M	+114.4%

DXCM Q2 2017 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena